Rethinking credible evidence synthesis
| dc.contributor.author | Doshi, Peter | |
| dc.contributor.author | Jones, Mark A., B.Sc., Ph.D. | |
| dc.contributor.author | Jefferson, Tom | |
| dc.date.accessioned | 2017-05-25T01:21:21Z | |
| dc.date.available | 2017-05-25T01:21:21Z | |
| dc.date.issued | 2012-01-17 | |
| dc.identifier.citation | Doshi, P., Jones, M., Jefferson, T. (2012). Rethinking credible evidence synthesis. BMJ, 344. DOI: 10.1136/bmj.d7898 | |
| dc.identifier.uri | http://hdl.handle.net/10713/6618 | |
| dc.description | After publication of a Cochrane review into the effectiveness of oseltamivir in 2009, the reviewers got access to thousands of pages of previously unavailable data. The authors describe how it shook their faith in published reports and changed their approach to systematic reviews. | |
| dc.description.uri | http://bmj.com/cgi/content/full/bmj.d7898?ijkey=Wf57Ta3w1rCIeRR&keytype=ref | |
| dc.language.iso | en_US | en_US |
| dc.publisher | BMJ Publishing Group | en_US |
| dc.subject | clinical study reports | en_US |
| dc.subject | Cochrane systematic review as topic | en_US |
| dc.subject | evidence synthesis | en_US |
| dc.subject | neuraminidase inhibitors | en_US |
| dc.subject.mesh | Access to Information | en_US |
| dc.subject.mesh | Oseltamivir | en_US |
| dc.title | Rethinking credible evidence synthesis | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.1136/bmj.d7898 | |
| dc.identifier.pmid | 22252039 | |
| dc.identifier.ispublished | No | en_US |
| dc.description.uriname | Click here for the free full-text article on publisher’s website | en_US |
| refterms.dateFOA | 2019-02-19T18:16:06Z |
